IRIS
RIZZOLI, Vittorio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.740
EU - Europa 3.417
AS - Asia 1.880
Continente sconosciuto - Info sul continente non disponibili 15
AF - Africa 3
OC - Oceania 2
Totale 9.057
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.641
CN - Cina 1.400
IE - Irlanda 757
SE - Svezia 715
FI - Finlandia 704
UA - Ucraina 551
DE - Germania 442
TR - Turchia 253
SG - Singapore 157
CA - Canada 99
IT - Italia 98
GB - Regno Unito 61
IN - India 36
BE - Belgio 30
RO - Romania 25
IR - Iran 22
EU - Europa 15
CZ - Repubblica Ceca 9
NL - Olanda 8
JP - Giappone 4
SK - Slovacchia (Repubblica Slovacca) 4
ES - Italia 3
HK - Hong Kong 3
NG - Nigeria 2
PL - Polonia 2
TW - Taiwan 2
AU - Australia 1
BG - Bulgaria 1
CM - Camerun 1
FR - Francia 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
RS - Serbia 1
Totale 9.057
Salva come PNG Salva come JPEG
Città #
Dublin 757
Chandler 711
Jacksonville 654
Beijing 296
Ashburn 254
Dearborn 253
Nanjing 235
Izmir 226
San Mateo 186
Princeton 160
Ann Arbor 141
Wilmington 98
Toronto 94
Shanghai 91
Shenyang 87
Nanchang 81
Singapore 75
Kunming 74
Hebei 65
Düsseldorf 63
Helsinki 63
Jinan 62
Boardman 59
Hefei 58
Des Moines 49
Parma 47
Woodbridge 40
New York 38
Changsha 35
Jiaxing 35
Tianjin 34
Bremen 33
Brussels 30
Los Angeles 28
Kocaeli 26
Pune 26
Leawood 25
Guangzhou 24
Seattle 24
Grafing 22
Zhengzhou 20
Hangzhou 19
Norwalk 19
Augusta 18
Ningbo 16
Focsani 15
Mestre 14
Monmouth Junction 13
Ardabil 12
Fremont 12
Haikou 12
Houston 11
Lanzhou 11
Fuzhou 10
Taizhou 10
Timisoara 10
Auburn Hills 8
Borås 8
Brno 7
Chongqing 7
Taiyuan 7
Chengdu 6
Amsterdam 5
Edinburgh 5
Milan 5
Trezzano Sul Naviglio 5
Wuhan 5
Bratislava 4
Cambridge 4
Rockville 4
Sabz 4
Southend 4
Torrile 4
Xian 4
Baotou 3
Chicago 3
Jinhua 3
Kyoto 3
Madrid 3
Montréal 3
Mumbai 3
Orange 3
Shaoxing 3
Ahmedabad 2
Bergamo 2
Bologna 2
Changchun 2
Frankfurt am Main 2
Lagos 2
Mountain View 2
New Orleans 2
Olomouc 2
Pisa 2
Quzhou 2
Rome 2
Sacramento 2
St Louis 2
Taipei 2
Walnut 2
Warsaw 2
Totale 5.738
Salva come PNG Salva come JPEG
Nome #
Angiopoietin-1 and Osteopontin Expression by CD138+ Myeloma Cells Rather Than VEGF and CD45 Correlates with Bone Marrow Angiogenesis in Multiple Myeloma Patients at the Diagnosis 111
Diabetes impairs hematopoietic stem cell mobilization by altering niche function 101
Hypoxia and Hypoxia Inducible Factor (HIF)-1{alpha} in Multiple Myeloma: Effect on the Pro-Angiogenic Signature of Myeloma Cells and the Bone Marrow Microenvironment 101
Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia 98
Are the Myeloma bone microevironment cells tumoral or not? 97
CC-4047 (Pomalidomide) inhibits multiple myeloma-induced osteoclast formation targeting RANKL in the bone marrow microenvironment 91
Human myeloma cells produce angiopoietin-1 but not angiopoietin-2: potential relationship with myeloma-induced angiogenesis 90
Hypoxia and hypoxia inducible factor (HIF)-1α in Multiple Myeloma patients: role in the angiogenic switch 90
HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients 90
Activation of non-canonical wnt pathway in human mesenchymal cells affects osteogenic differentiation: a potential target in Multiple Myeloma microenvironment 89
Bone marrow endothelial cells carry bcr/abl fusion gene from chronic myeloid leukemia patients 86
Chemokine receptors CXCR3 and CXCR4 expression in B cell and plasma cell malignancy 84
The Immunomodulatory drugs Lenalidomide and Pomalidomide inhibit multiple myeloma-induced osteoclast formation and RANKL/OPG ratio in myeloma microenvironment targeting the expression of adhesion molecules 84
The homeobox gene HOXB7 regulates the production of pro-angiogenic molecole by myeloma cells and it is a target in myeloma-induced angiogenesis 84
BCR/ABL fusion gene is detected in chronic myeloid leukemia endothelial cells 83
HOXB7 is a key gene involved in Myeloma cell growth and Myeloma-induced angiogenesis in Multiple Myeloma patients 83
The IMID CC-4047 (Pomalidomide) inhibits myeloma-induced osteoclast formation 82
Angiopoietins expression by human myeloma cells 78
IL-7 is induced by IL-6 in human myeloma cells: role in multiple myeloma 78
Analysis of lineage involvment in Philadelphia chromosome positive acute lymphoblastic leukaemia 77
Pro-angiogenetic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 74
Autologous transplant for chronic myelogenous leukemia using marrow treated ex vivo with mafosfamide. 74
Angiopoietin-1 and osteopontin expression by CD138+myeloma cells rather than VEGF and CD45 correlates with bone marrow angiogenesis in Multiple Myeloma patients at the diagnosis. 74
Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation 73
Angiogenic switch in multiple myeloma patients 73
Do human myeloma cells directly produce basic FGF? 73
Angiogenic properties of human myeloma cells: role of angiopoietin system 72
Oxygen tension in the bone marrow (BM) of patients with malignant and indolent monoclonal gammopathy: role of hypoxia and hypoxia-inducible factor (HIF)-1{alpha} in the regulation of gene expression and pro-angiogenic profiles of CD138+ cells 72
HOXB7 is critically involved in Multiple Myeloma-induced angiogenic switch 72
Angiopoietin-1 and myeloma-induced angiogenesis 71
Expression and role of chemokine receptor CXCR3 in multiple myeloma 71
Hematologic malignancies with extramedullary spread of disease. Case 1. Multiple myeloma with extramedullary involvement of the pleura and testes 71
Amifostine (WR-2721) selective protection against melphalan genotoxicity 70
VASCULAR ENDOTHELIAL GROWTH FACTOR SECRETION BY MYELOMA CELLS IS INHIBITED BY DOWN-MODULATING ERK PROTEIN KINASE ACTIVITY 70
Pan-aurora kinase inhibitor MK-0457 synergistically potentiates Apo2l/TRAIL cytotoxicity in Multiple Mieloma cells sensitive and resistant to bortezomib 70
Macrophage inflammatory protein (MIP)-3 alpha/CCL20 and its receptor CCR6 are overexpressed in the bone microenvironment and involved in osteoclast formation in multiple myeloma patients. 70
Non canonical wnt signal pathway (Wnt5a/ror2) activation stimulates the osteogenic differentiation process of bone mesenchymal cells being a potential target in multiple myeloma bone disease 69
Ectopic production of osteopontin by human myeloma cells and its involvement in myeloma induced angiogenesis 69
Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease 69
Osteopontin is produced by human multiple myeloma cells 68
Production of Wnt inhibitors by myeloma cells: potential effects on canonical Wnt pathway in the bone microenvironment 68
CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survival. 67
Autologous bone marrow transplantation in acute myeloid leukemia: a single center experience 67
DNA damage by tobacco smoke and some antiblastic drugs evaluated using the Comet assay 66
Bleomycin Genotoxicity and Amifostine (WR-2721) Cell Protection in Normal Leukocytes versus K562 Tumoral Cells 66
Paracrine rather than autocrine basic FGF (bFGF) loop in multiple myeloma 65
CC-Chemokine Ligand 20/Macrophage Inflammatory Protein-3A and CC-Chemokine Receptor 6 Are Overexpressed in Myeloma Microenvironment Related to Osteolytic Bone Lesions 65
Beta-catenin depended and independent effects induced by myeloma cells in human and murine osteoblasts and osteoblast progenitors. 64
Increased osteocyte apoptosis in Multiple Myeloma patients: a potential role in bone remodeling alterations related to osteolytic bone lesions 64
Angiogenic switch in multiple myeloma 63
Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis 63
BCL2 oncogene protein expression in human hematopoietic precursors during fetal life. 63
Myeloma cells inhibit the non-canonical wnt co-receptor ror2 in human mesenchymal/osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on mm-induced impairment of the osteogenic differentiation process 63
A translocation t(4;13)(q21;q14) as single clonal chromosomal abnormality in a parathyroid adenoma 63
Association of folate transporter SLC19A1 polymorphisms with the outcome of multiple myeloma after chemotherapy and tandem autologous transplantation. 62
In vitro and In vivo evidences of osteocytes involvement in myeloma-induced osteolysis 62
p29ING4 regulates the production of pro-angiogenic molecules by human myeloma cells in normoxic and hypoxic conditions being involved in myeloma-induced angiogenesis. 62
Human myeloma cells produce angiopoietin-1: potential relationship with myeloma-induced angiogenesis 61
Bone osteoblastic and mesenchymal stromal cells lack primarily tumoral features in multiple myeloma patients 61
Combined treatment with the MEK inhibitor PD0325901 and Arsenic Trioxide has potent anti-tumor activity in vivo against human multiple myeloma xenograft model. 61
The new tumor suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of pro-angiogenic molecules by myeloma cells and suppresses hypoxia inducible factor (HIF)-1{alpha} activity being involved in myeloma-induced angiogenesis. 61
Human myeloma cells express IL-7 mRNA and secrete IL-7 in presence of IL-6 60
Osteogenic differentiation of mesenchymal stem cells in multiple myeloma: identification of potential therapeutic targets 60
A distintive nuclear morfology in three cases of acute myeloid leukaemia associated with loss HLA-DR expression and FTL3 internal tandem duplication 60
Assessment of the efficacy of a last-generation polyvalent immunoglobulin in the treatment of idiopathic thrombocytopenic purpura. 60
Multiple myeloma patient with unusual extramedullary involvement 60
Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation. 60
Expression of pro-angiogenetic factors by myeloma cells: role of the angiopoietin system 59
EPIRUBICIN PLUS G-CSF ELICITED PERIPHERAL BLOOD PROGENITOR CELL MOBILIZATION IS SIGNIFICANTLY ENHANCED BY AMIFOSTINE 59
Human myeloma cells production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 59
Purging the bone marrow in non-Hodgkin's lymphomas. Is there any evidence of its value? 59
Down-modulation of ERK protein kinase activity suppresses human myeloma cell proliferation and myeloma-induced angiogenesis by VEGF inhibition 58
Bone marrow transplantation in patients with acute leukemia 58
HUMAN MYELOMA CELLS EXPRESS THE BONE REGULATING GENE RUNX2/CBFA1 AND PRODUCE OSTEOPONTIN THAT IT IS INVOLVED IN MYELOMA INDUCED ANGIOGENESIS 57
VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group 57
Laparoscopic splenectomy: comments on the surgical technic 57
Autotransplantation in acute leukemia. 57
Clonogenic potential and phenotypic analysis of CD34+ cells mobilized by different chemotherapy regimens 57
The proteasome inhibitor bortezomib affects osteoblastogenesis and bone formation in vitro and in vivo in multiple myeloma patients. 57
Evaluation of amifostine (WR-271) cytoprotection against in vitro bleomycin-induced clastogenicity in human leukocytes by SCGE assay 56
Non-infusional vs intravenous consolidation chemotherapy in elderly patients withacute myeloid leukemia: final results of the EORTC-GIMEMA AML-13 randomized phase 56
RANKL is critically involved in the physiopathology of multiple myeloma 56
IL-7 is produced by myeloma cells in presence of IL-6 56
MYELOMA CELLS BLOCK RUNX2/CBFA1 ACTIVITY IN HUMAN BONE MARROW OSTEOBLAST PROGENITORS AND INHIBIT OSTEOBLAST FORMATION AND DIFFERENTIATION 55
Gamma-rays from Mössbauer sources: a low-dose approach to cancer therapy 55
Down-modulation of ERK protein kinase activity inhibits vascular endothelial growth factor (VEGF) secretion by human myeloma cell lines 55
The proteasome inhibitor bortezomib stimulates the osteogenic differentiation of mesenchymal cells in vitro and may increase osteoblast formation in vivo in multiple myeloma patients. 53
Interleukin-3 (IL-3) is overexpressed by T lymphocytes in multiple myeloma patients 53
Basic fibroblast growth factor (bFGF) production and role in multiple myeloma patients 52
TRAPIANTO DI CELLULE STAMINALI EMOPOIETICHE 52
Primitive hematopoietic progenitors within mobilized blood are spared by uncontrolled rate freezing 52
Targeting pathways mediating bone disease. 52
DKK-1 and sFRP-3 expression by myeloma cell and bone marrow plasma levels in multiple myeloma and MGUS patients: Potential relationship with bone status. 52
The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment 52
CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF. 52
Role of tumor necrosis factor-related activation-induced cytokine (TRANCE) in multiple myeloma 51
Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation 51
New insight in the mechanism of osteoclast activation and formation in multiple myeloma: focus on the receptor activator of NF-kappaB ligand (RANKL) 50
The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients 50
Do human myeloma cells directly produce the receptor activator of nuclear factor kappaB ligand (RANKL) or induce RANKL in the bone marrow microenvironment? 49
Totale 6.703
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.314
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.314
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201955 0 0 0 0 0 0 0 0 0 0 0 55
2019/20202.040 368 346 125 18 163 178 258 35 156 192 54 147
2020/20211.166 21 142 113 4 157 6 120 9 274 37 254 29
2021/2022784 11 2 5 56 16 31 94 137 35 85 80 232
2022/20232.743 357 295 171 193 250 284 53 151 891 11 74 13
2023/2024866 40 105 21 16 75 196 82 89 22 41 69 110
Totale 9.150